BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17050037)

  • 21. The effects of CRF and urocortins on the preference for social novelty of mice.
    Bagosi Z; Czébely-Lénárt A; Karasz G; Csabafi K; Jászberényi M; Telegdy G
    Behav Brain Res; 2017 May; 324():146-154. PubMed ID: 28189757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
    Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
    Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
    Brar BK; Chen A; Perrin MH; Vale W
    Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats.
    Ciccocioppo R; Martin-Fardon R; Weiss F; Massi M
    Neuroreport; 2001 May; 12(6):1145-9. PubMed ID: 11338181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors.
    Zorrilla EP; Schulteis G; Ormsby A; Klaassen A; Ling N; McCarthy JR; Koob GF; De Souza EB
    Brain Res; 2002 Oct; 952(2):200-10. PubMed ID: 12376180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between nociceptin/orphanin FQ (N/OFQ) and GABA in response to feeding.
    Tajalli S; Jonaidi H; Abbasnejad M; Denbow DM
    Physiol Behav; 2006 Oct; 89(3):410-3. PubMed ID: 16904711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
    Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urocortin, corticotropin releasing factor-2 receptors and energy balance.
    Cullen MJ; Ling N; Foster AC; Pelleymounter MA
    Endocrinology; 2001 Mar; 142(3):992-9. PubMed ID: 11181511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
    Martinez V; Wang L; Million M; Rivier J; Taché Y
    Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
    Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
    Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
    Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
    Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
    Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
    Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats.
    Wang L; Stengel A; Goebel-Stengel M; Shaikh A; Yuan PQ; Taché Y
    Peptides; 2013 Jan; 39():164-70. PubMed ID: 23183626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat.
    Turnbull AV; Vaughan J; Rivier JE; Vale WW; Rivier C
    Endocrinology; 1999 Jan; 140(1):71-8. PubMed ID: 9886809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic regulation of nociceptin/orphanin FQ and corticotropin-releasing factor system genes in frustration stress-induced binge-like palatable food consumption.
    Pucci M; Micioni Di Bonaventura MV; Giusepponi ME; Romano A; Filaferro M; Maccarrone M; Ciccocioppo R; Cifani C; D'Addario C
    Addict Biol; 2016 Nov; 21(6):1168-1185. PubMed ID: 26387568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of urocortin 2 secreted by the pituitary in the stress-induced suppression of luteinizing hormone secretion in rats.
    Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E567-75. PubMed ID: 20663987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.
    Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP
    J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.